Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
By G. H. Nancollas, R. Tang, R. Phipps, Zachary J. Henneman, S. Gulde, Wenju Wu, A. Mangood, R. Russell, H. EbetinoFrank. Bone, 2006
851 citations recorded by the source corpus.
Subfields: Oncology, Orthopedics and Sports Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/ed2b3df41bc2742739787966639d0d61f7f227f7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Orthopedics and Sports Medicine
Citations in the corpus
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research (2010, background): “The high affinity of BPs for bone mineral((56)) and their long-term retention in bone((57)) are of some concern because continued accumulation of BPs or persistent reduction of remodeling for prolonged treatment periods eventually could increase the risk of fracture, even in the face of increased bo”
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy (2008, methodology): “Asterisk The alendronate data are from the highest concentration tested (~3 μmol) [24] Osteoporos Int (2008) 19:733–759 739”